Genetics of Pancreatic Cancer and Its Implications on Therapy

被引：13

作者：

Tatarian, Talar ^{[1
]}

Winter, Jordan M. ^{[2
]}

机构：

[1] Thomas Jefferson Univ Hosp, Dept Surg, Jefferson Pancreas Biliary & Related Canc Ctr, Sidney Kimmel Med Coll, 1015 Walnut St,Suite 620, Philadelphia, PA 19107 USA

[2] Thomas Jefferson Univ Hosp, Dept Surg, Jefferson Pancreas Biliary & Related Canc Ctr, Sidney Kimmel Med Coll, 1025 Walnut St,Suite 605, Philadelphia, PA 19107 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2016年 / 96卷 / 06期

关键词：

Pancreatic cancer; Genetics; Personalized medicine; Targeted therapy; PHASE-II TRIAL; GROWTH-FACTOR RECEPTOR; DUCTAL ADENOCARCINOMA; 1ST-LINE TREATMENT; PLUS GEMCITABINE; OPEN-LABEL; K-RAS; MUTATIONS; TRASTUZUMAB; KRAS;

D O I：

10.1016/j.suc.2016.07.014

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Over the past decade, emerging technologies have provided new insights into the genomic landscape of pancreatic ductal adenocarcinoma (PDA). In addition to the commonly recognized genetic drivers of pancreatic carcinogenesis (KRAS, CDKN2A, TP53, SMAD4), new genes and pathways have been implicated. However, these efforts have not identified any new high-frequency actionable mutations, limiting the success of mutation-targeted therapy in PDA. This article provides a report on the current landscape of pancreas cancer genetics and targeted therapeutics.

引用

页码：1207 / +

页数：16

共 50 条

[21] The molecular genetics of pancreatic cancer
Howe, JR
Conlon, KC
SURGICAL ONCOLOGY-OXFORD, 1997, 6 (01): : 1 - 18
[22] Molecular genetics of pancreatic cancer
Slebos, RJC
Ceha, HM
Kern, SE
Hruban, RH
PANCREATIC CANCER: ADVANCES IN MOLECULAR PATHOLOGY, DIAGNOSIS & CLINICAL MANAGEMENT, 1998, : 65 - 82
[23] FAMILIAL PANCREATIC-CANCER AND THE GENETICS OF PANCREATIC-CANCER
LUMADUE, JA
GRIFFIN, CA
OSMAN, M
HRUBAN, RH
SURGICAL CLINICS OF NORTH AMERICA, 1995, 75 (05) : 845 - &
[24] PROSTATE CANCER GENETICS CLINIC: GERMLINE GENETIC TESTING IN PRACTICE AND ITS IMPLICATIONS FOR PRECISION THERAPY AND FAMILY COUNSELING
Pouv, D.
Sokolova, A.
Cheng, H.
JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 : A194 - A194
[25] Genetics of pancreatic neuroendocrine tumors: implications for the clinic
Pea, Antonio
Hruban, Ralph H.
Wood, Laura D.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (11) : 1407 - 1419
[26] Molecular changes in pancreatic cancer: implications for molecular targeting therapy
Demetter, P.
Marechal, R.
Verset, L.
Salmon, I.
Bachet, J. -B.
Van Laethem, J. -L.
ACTA GASTRO-ENTEROLOGICA BELGICA, 2012, 75 (02): : 210 - 214
[27] Personalized Medicine in Pancreatic Cancer: Prognosis and Potential Implications for Therapy
Christine A. Iacobuzio-Donahue
Journal of Gastrointestinal Surgery, 2012, 16 : 1651 - 1652
[28] Molecular Pathology of Pancreatic Cancer: Implications for Molecular Targeting Therapy
Furukawa, Toru
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (11) : S35 - S39
[29] Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer
Rachagani, Satyanarayana
Macha, Muzafar A.
Heimann, Nicholas
Seshacharyulu, Parthasarathy
Haridas, Dhanya
Chugh, Seema
Batra, Surinder K.
ADVANCED DRUG DELIVERY REVIEWS, 2015, 81 : 16 - 33
[30] Personalized Medicine in Pancreatic Cancer: Prognosis and Potential Implications for Therapy
Iacobuzio-Donahue, Christine A.
JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (09) : 1651 - 1652

← 1 2 3 4 5 →